Clinical therapy aimed at increasing erythrocyte n-3 polyunsaturated fatty acids (PUFAs) represents a “promising strategy for breast cancer prevention,” say researchers.
A comprehensive new meta-analysis underpins previous evidence and adds further credence to the positive impact of omega-3 fatty acids (n-3 PUFAs) on high blood pressure (BP).
Fish oil supplementation has shown to lower blood pressure increase in seniors, but no significant improvement was seen in cognitive health, according to a 12-month RCT conducted in New Zealand.
The South Korean authorities have released a proposal on how oxidation should be measured in EPA and DHA products, in what is being seen as a move to bridge the gap between locally-made and imported products.
Omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are commonly associated with a reduced risk of coronary heart disease (CHD), but new research highlights how the ratio of EPA to DHA matter in influencing different...
Japan’s Ise Foods, known for being the first firm to retail eggs with a food with function claim (FFC) has announced intentions to expand its business in Asia.
Consuming high dose of EPA improves attention in ADHD children, according to a study jointly conducted by King’s College London and China Medical University in Taiwan.
A new lab partnership will help drive omega-3s research in the Asia Pacific region, according to OmegaQuant, a firm that has developed a simple blood test to measure levels of these important nutrients.
A database that includes 4,000-plus clinical trials on EPA and DHA omega-3s will help companies with claims substantiation, and provide ready access to significant scientific data to counter negative consumer media articles, says GOED’s executive director.
Polyunsaturated fatty acids (PUFAs), and in particular eicosapentaenoic acid (EPA), has shown the strongest evidence for improving cognitive disorders, such as depression, according to a meta-review.
Continuing research into a genetically engineered canola source of omega-3 has promised plant-derived EPA and DHA on par with fatty acids from fish and algae.
Omega-3 fats delivered using a proprietary self-micro-emulsifying system may be more bioavailable to the human body than the standard ethyl ester formulation, according to a new study funded by Pharmavite.
Chinese/American company Lyxia has debuted as a new player in the algae omega-3s space with a highly refined EPA ingredient from a photosynthetic strain.
Results from an omega-3 study found a positive link between treatment using EPA and cardiovascular outcomes. It was backed by pharmaceutical company Amarin, which enjoyed a 300% surge in shares after the study results were announced.
